Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 3 papers. Top paper: “Belzutifan for von Hippel-Lindau disease-associated renal cell carcinoma and other neoplasms (LITESPARK-004): 50 months follow-up from a single-arm, phase 2 study”.
Othon Iliopoulos, Kathryn E. Beckermann, Vivek Narayan, Benjamin L Maughan, Stéphane Oudard +9 more
Zuoxiang Peng, Jerry Cornell, Peng Ye, Hua He, Yuhan Zou
Xuenan Mi, Jerry Cornell, Wan Tang, Tanika N. Kelly, Hui Shen +3 more